U.S. stocks were lower, with the Dow Jones index falling around 400 points on Monday.Shares of ImmunityBio, Inc. (NASDAQ:IBRX) rose sharply on Monday after the company reported better-than-expected quarterly financial results.ImmunityBio reported quarterly losses of 6 cents per share which beat the analyst consensus estimate of losses of 9 cents per share. The company reported quarterly sales of $38.285 million which beat the analyst consensus estimate of $37.020 million.ImmunityBio shares jumped 22.2% to $ ...

Investors with a lot of money to spend have taken a bullish stance on Eli Lilly (NYSE:LLY).And retail traders should know.We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with LLY, it often means somebody knows something is about to happen.So how do we know what these investors just did? Today, Benzinga's options scanner spotted 26 ...

Deep-pocketed investors have adopted a bearish approach towards Amazon.com (NASDAQ:AMZN), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in AMZN usually suggests something big is about to happen.We gleaned this information from our observations today when Benzinga's options scanner highlighted 85 extraordinary options activities for Amazon ...

Full Transcript: i-80 Gold Q4 2025 Earnings Callby Benzinga Insights Benzinga Staff WriterFollowi-80 Gold (AMEX:IAUX) released fourth-quarter financial results and hosted an earnings call on Friday. Read the complete transcript below.Benzinga APIs provide real-time access to earnings call transcripts and financial data. Visit https://www.benzinga.com/apis/ to learn more.View the webcast at https://app.webinar.net/r3PBKd1OR4qFull TranscriptOPERATORRichard YoungPaul HuetRyan SnowRichard YoungOPERATORRichard ...

Prediction market traders on Polymarket are nearly certain New York City’s weekend snowfall crossed the 20-inch mark. The 20+ inch outcome now sits at 56%, with over $439,000 in volume on the entire market. The 18–20 inch bracket has collapsed to 36%, and 16–18 inches is down to just 3%.A 20+ inch reading at Central Park has only been recorded six times since 1869, the last being Blizzard Jonas in January 2016, which still holds the all-time record at 27.5 inches.NYSE Expected To OpenMarkets are expected to ...

Gossamer Bio Inc. (NASDAQ:GOSS) dropped during early trading on Monday after the company shared topline results from the Phase 3 PROSERA study evaluating seralutinib in pulmonary arterial hypertension.PAH is defined by high blood pressure in the lung arteries due to narrowed, damaged, or destroyed vessels, forcing the heart’s right side to overwork and potentially fail.Disappointing Trial DataAt Week 24, patients receiving seralutinib showed a median change of +28.2 meters in the Six-Minute Walk Distance (6 ...

U.S. stocks traded mixed this morning, with the Dow Jones index gaining around 0.1% on Monday.Following the market opening Monday, the Dow traded up 0.06% to 49,655.48 while the NASDAQ fell 0.09% to 22,864.38. The S&P 500 also rose, gaining, 0.06% to 6,913.49.Check This Out: How To Earn $500 A Month From Goldman Sachs Stock Ahead Of Q4 EarningsLeading and Lagging SectorsEnergy shares gained by 1.2% on Monday.In trading on Monday, consumer discretionary stocks fell by 1.3%.Top HeadlineDomino's Pizza Inc. (NA ...

GRAIL Inc. (NASDAQ:GRAL) shares are down during Monday's premarket session following the release of results from the NHS-Galleri trial, which evaluated the effectiveness of the Galleri test in reducing late-stage cancer diagnoses.NHS-Galleri Trial ResultsThe NHS-Galleri trial results showed a favorable trend in reducing Stage IV cancer diagnoses, although the primary endpoint was not met. On Friday, GRAIL stock closed almost 51% lower.The trial evaluated annual multi-cancer screening with the Galleri test i ...

A tenant representing roughly 2% of annual revenue — approximately $200 million — has defaulted on payments. Consensus estimates still project 6.5% AFFO per share growth.That $2.47 estimate follows a quarter in which American Tower reported continued operating expansion across both its tower and data center segments.In the third quarter of 2025, attributable AFFO per share reached $2.78, representing approximately 10% year-over-year growth. Consolidated revenue increased approximately 8% year over year to $ ...

Brighthouse Financial, Inc. (NASDAQ:BHF) will release earnings results for its fourth quarter during the week of Feb. 23.Analysts expect the Charlotte, North Carolina-based company to report quarterly earnings at $5.19 per share, up from $5.07 per share in the year-ago period. The consensus estimate for Brighthouse Financial's quarterly revenue is $2.24 billion, versus $2.27 billion a year earlier, according to data from Benzinga Pro.On Feb. 12, Brighthouse Financial's shareholders approved the $4.1 billion ...